Ramon Velazquez, Ph.D.

Affiliations: 
2008-2014 Psychology Cornell University, Ithaca, NY, United States 
 2014-2019 Biodesign Institute Arizona State University, Tempe, AZ, United States 
Area:
Neurodegeneration
Website:
https://isearch.asu.edu/profile/1187887
Google:
"https://scholar.google.com/citations?user=iZ9JH2EAAAAJ&hl=en&oi=sra"
Bio:

Dr. Ramon Velazquez is an Assistant Research Professor at the Neurodegenerative Disease Research Center at the Biodesign Institute - Arizona State University (ASU). His research interests include identifying novel therapeutic targets for neurodegenerative disorders such as Alzheimer’s disease (AD) and Down Syndrome (DS). In particular, he focuses on early molecular events that trigger the progression of these diseases. He is also interested in drug discovery and dietary supplementation of B-like vitamins as a way to prevent disease progression. Dr. Velazquez received his doctoral degree at Cornell University and worked in the laboratory of Dr. Barbara Strupp in collaboration with training in the laboratory of Dr. Elliot Mufson at Rush University. Dr. Velazquez was funded by the National Science Foundation (NSF) Pre-Doctoral fellowship as a graduate student. He completed his Post-Doctoral training in molecular biology and neuroscience at ASU, where he was independently funded by the Alzheimer’s Association to investigate a novel therapeutic drug therapy (Pim1-inhibitor) leveraging the use of nanoparticle encapsulation to halt the progression of AD-pathology. Additionally, he was funded through a NSF Post-Doctoral fellowship to elucidate the exact molecular mechanisms linked to Choline’s cognitive and neural benefits. Dr. Velazquez’s ultimate goal is to progress science while consecutively helping those who suffer from insidious neurodegenerative diseases.
(Show less)

Mean distance: 106866 (cluster 29)
 
SNBCP
Cross-listing: PsychTree

Parents

Sign in to add mentor
Diane W. Lee research assistant California State University Long Beach
Barbara Strupp grad student 2008-2014 Cornell
Elliott Mufson grad student 2012-2014 Rush University
 (Trained in lab in collaboration)

Children

Sign in to add trainee
Zoe Lusher research assistant 2010-2012 Cornell
An Tran research assistant 2015-2017 Arizona State
Nikhil Dave research assistant 2015-2018 Arizona State
Savannah L Tallino grad student Arizona State Univ
Marc A. Mifflin grad student 2017-2020 Arizona State

Collaborators

Sign in to add collaborator
Stephen Ginsberg collaborator 2012-2014 Nathan Kline Institute, New York University Medical School
Matthew J. Huentelman collaborator 2019-2019 TGen (Cell Biology Tree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

de Ávila C, Suazo C, Nolz J, et al. (2023) Reduced gene expression in neocortical and limbic brain regions in female Alzheimer's patients correlates with cognitive and neuropathological phenotypes. Biorxiv : the Preprint Server For Biology
Judd JM, Jasbi P, Winslow W, et al. (2023) Inflammation and the pathological progression of Alzheimer's disease are associated with low circulating choline levels. Acta Neuropathologica
Judd JM, Jasbi P, Winslow W, et al. (2023) Low circulating choline, a modifiable dietary factor, is associated with the pathological progression and metabolome dysfunction in Alzheimer's disease. Biorxiv : the Preprint Server For Biology
Tallino S, Winslow W, Velazquez R. (2023) Pathological trajectory in the Ts65Dn model of Down syndrome. Aging. 15: 295-297
Dave N, Judd JM, Decker A, et al. (2023) Dietary choline intake is necessary to prevent systems-wide organ pathology and reduce Alzheimer's disease hallmarks. Aging Cell. e13775
Winstone JK, Pathak KV, Winslow W, et al. (2022) Glyphosate infiltrates the brain and increases pro-inflammatory cytokine TNFα: implications for neurodegenerative disorders. Journal of Neuroinflammation. 19: 193
Tallino S, Winslow W, Bartholomew SK, et al. (2022) Temporal and brain region-specific elevations of soluble Amyloid-β in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease. Aging Cell. e13590
Powers BE, Velazquez R, Strawderman MS, et al. (2021) Maternal Choline Supplementation as a Potential Therapy for Down Syndrome: Assessment of Effects Throughout the Lifespan. Frontiers in Aging Neuroscience. 13: 723046
Winslow W, McDonough I, Tallino S, et al. (2021) IntelliCage Automated Behavioral Phenotyping Reveals Behavior Deficits in the 3xTg-AD Mouse Model of Alzheimer's Disease Associated With Brain Weight. Frontiers in Aging Neuroscience. 13: 720214
Dave N, Vural AS, Piras IS, et al. (2021) Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer's disease and related tauopathies. Acta Neuropathologica
See more...